Extended Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome

NCT01223586 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 238

Last updated 2012-04-24

No results posted yet for this study

Summary

The objective of this study is to verify the relationship between coronary plaque regression and cardiovascular prevention in long term follow up of the Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome (JAPAN-ACS) study \[NCT00242944\]. In addition, the effect of serum lipid levels or different type of statins on cardiovascular prevention will also be examined.

Conditions

Sponsors & Collaborators

  • Yamaguchi University Hospital

    collaborator OTHER
  • Kyoto University

    lead OTHER

Principal Investigators

  • Masunori Matsuzaki, MD, PhD · Professor of Division of Cardiology, Department of Medicine and Clinical Science, Yamaguchi University Graduate School of Medicine

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-11-30
Primary Completion
2011-05-31
Completion
2011-05-31

Countries

  • Japan

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01223586 on ClinicalTrials.gov